DxNow, Inc. Receives FDA 510(k) Clearance for ZyMand#333;t(TM) ICSI and ZyMand#333;t(TM) Multi Sperm Separation Devices

Novel Devices Advance Fertility Treatment for Millions of Couples Striving to Conceive GAITHERSBURG, Md., March 15, 2018 -- (Healthcare Sales & Marketing Network) -- DxNow, Inc., a privately held medical device company, announces receipt of FDA 510(k) ... Devices, FDA DxNow, ZyMōt, assisted reproductive technology
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news